Following the Courses, former ADVAC participants become part of the ADVAC alumni network. ADVAC alumni meetings are regularly organized in the context of major vaccine-related meetings (e.g. SAGE, IDSA, ESPID,....).
WEBINAR
Discussion topic:
Post-COVID era: facilitating access and acceptance to immunization in Europe
Presenters:
Current situation in Europe for access and acceptance, Siddhartha Sankar Datta, Regional Adviser, Vaccine-preventable Diseases and Immunization, WHO Regional Office for Europe.
Establishing a dialogue with the vaccine-hesitant patients, the example of the JITSUVAX project, Angelo Fasce, Philosopher of science and postdoctoral researcher, Faculty of Medicine of the University of Coimbra, Portugal.
WEBINAR
Discussion topic:
Evidence-informed decision-making in Real Settings: How to make sure politicians and decision-makers listen to the advice of immunization experts?
Presenters:
The example of the COVID immunization policy in France, Brigitte Autran, Chair of the French Surveillance and Response Advisory Committee (Comité de veille et d’anticipation des risques sanitaires, COVARS).
The example of the COVID immunization policy in Finland, Hanna Nohynek, Chair WHO SAGE, Secretary of the Finnish NITAG and Department of Health Security in the Finnish Institute for Health and Welfare (THL), Finland.
WEBINAR
Discussion topic:
Overcoming the challenges to measles and rubella elimination in south-east asia
Presenters:
Prof T. Jacob John, and Dr. Firdausi Qadri
WEBINAR
Discussion topic:
One health: does it work? The example of Monkeypox
Presenters:
Update on the animal monkeypox: Yoshi Nakazawa
Update on the human monkeypox: Brett W. Petersen
WEBINAR
Discussion topic:
Industry and vaccine development – dispelling some myths
Presenters:
Penny Heaton, J&J and Brad Gessner, Pfizer
WEBINAR
Discussion topic:
The power and limitations of immunobridging studies:
the example of COVID-19 vaccines
Presenters:
Peter Dull, Bill & Melinda Gates Foundation
Marco Cavaleri, Head of Office Biological Health Threats and Vaccine Strategy, European Medicines Agency.